Research
Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target
Alterity Therapeutics (ATHE) has an average rating of buy and mean price target of $17.60, according to analysts polled by FactSet.
$ATHE
$ATHE
1 story mentioning ATHEUpdated 7d ago
Every FINWIRES story that references ATHE, newest first.
What are analysts saying about ATHE?
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
